Literature DB >> 28888249

Do Corticosteroids Prevent Biphasic Anaphylaxis?

Waleed Alqurashi1, Anne K Ellis2.   

Abstract

Anaphylaxis is a severe hypersensitivity reaction that is rapid in onset and can result in death. The pattern of an anaphylactic reaction can be uniphasic (or monophasic), biphasic (also called delayed or late phase), or refractory in nature. The most widely cited definition of biphasic anaphylaxis is a recurrence of anaphylactic symptoms after initial resolution despite no further exposure to the trigger. Corticosteroids are thought by some to prevent the development of biphasic symptoms and, therefore, commonly used in the emergency treatment of anaphylaxis but this has not been systemtically analyzed. In this review, Ovid MEDLINE, Ovid EMBASE, Web of Science, and Scopus were searched for articles using "anaphylaxis" combined with the key terms "biphasic" and/or "corticosteroids" and/or "epinephrine." A total of 31 appropriate studies were identified. Biphasic anaphylactic reactions are more likely to occur in moderate to severe anaphylaxis or when anaphylaxis is not treated with timely epinephrine. Because of the potential detrimental adverse effects of corticosteroids and lack of compelling evidence demonstrating an effective role in reducing anaphylaxis severity or preventing biphasic anaphylaxis, we do not advocate for their routine use in anaphylaxis.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Biphasic anaphylaxis; Corticosteroids; Epinephrine

Mesh:

Substances:

Year:  2017        PMID: 28888249     DOI: 10.1016/j.jaip.2017.05.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  16 in total

1.  Emergency treatment of anaphylaxis: concise clinical guidance.

Authors:  Andrew F Whyte; Jasmeet Soar; Amy Dodd; Anna Hughes; Nicholas Sargant; Paul J Turner
Journal:  Clin Med (Lond)       Date:  2022-07       Impact factor: 5.410

Review 2.  Evidence update for the treatment of anaphylaxis.

Authors:  Amy Dodd; Anna Hughes; Nicholas Sargant; Andrew F Whyte; Jasmeet Soar; Paul J Turner
Journal:  Resuscitation       Date:  2021-04-23       Impact factor: 5.262

3.  Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.

Authors:  Christophe Abi Zeid Daou; Mohammad A Natout; Nadine El Hadi
Journal:  J Med Virol       Date:  2021-06-06       Impact factor: 20.693

4.  Safely Reducing Hospitalizations for Anaphylaxis in Children Through an Evidence-Based Guideline.

Authors:  Lukas K Gaffney; John Porter; Megan Gerling; Lynda C Schneider; Anne M Stack; Dhara Shah; Kenneth A Michelson
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 9.703

Review 5.  Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities.

Authors:  Benjamin T Prince; Irene Mikhail; David R Stukus
Journal:  J Asthma Allergy       Date:  2018-06-20

6.  Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis.

Authors:  Marcus Shaker; Dana Wallace; David B K Golden; John Oppenheimer; Matthew Greenhawt
Journal:  JAMA Netw Open       Date:  2019-10-02

7.  Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).

Authors:  Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Matthias Fischer; Thomas Fuchs; Axel Heller; Florian Hoffmann; Isidor Huttegger; Thilo Jakob; Ludger Klimek; Matthias V Kopp; Claudia Kugler; Lars Lange; Oliver Pfaar; Ernst Rietschel; Franziska Rueff; Sabine Schnadt; Roland Seifert; Britta Stöcker; Regina Treudler; Christian Vogelberg; Thomas Werfel; Margitta Worm; Helmut Sitter; Knut Brockow
Journal:  Allergo J Int       Date:  2021-01-28

Review 8.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

Review 9.  Myths, facts and controversies in the diagnosis and management of anaphylaxis.

Authors:  Katherine Anagnostou; Paul J Turner
Journal:  Arch Dis Child       Date:  2018-06-16       Impact factor: 3.791

10.  Global Trends in Anaphylaxis Epidemiology and Clinical Implications.

Authors:  Paul J Turner; Dianne E Campbell; Megan S Motosue; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.